Telomerase expression in primary neuroblastomas

被引:21
作者
Reynolds, CP [1 ]
Zuo, JJ
Kim, NW
Wang, H
Lukens, JN
Matthay, KK
Seeger, RC
机构
[1] Univ So Calif, Childrens Hosp Los Angeles, Sch Med, Dept Pediat,Div Hematol Oncol, Los Angeles, CA 90027 USA
[2] Childrens Canc Grp, Arcadia, CA 91066 USA
[3] Geron Corp, Menlo Park, CA 94025 USA
[4] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37203 USA
[5] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
关键词
neuroblastoma; telomerase; tumour progression;
D O I
10.1016/S0959-8049(97)00287-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Maintenance of chromosomal telomeres is necessary for continued cell growth, and this is carried out in germline tissues by telomerase. In contrast to most somatic tissues, many tumours have telomerase activity. The RNA component of human telomerase (hTR) was measured by Northern analyses of 150 primary untreated neuroblastomas and compared with clinical stage at diagnosis. hTR expression > 33 (relative to cell Line control = 100) was seen in 41% of all tumours and the frequency of hTR > 33 increased with stage of disease. Expression of hTR may be involved in progression of neuroblastoma. (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码:1929 / 1931
页数:3
相关论文
共 22 条
[1]  
Avilion AA, 1996, CANCER RES, V56, P645
[2]  
BACCHETTI S, 1995, INT J ONCOL, V7, P423
[3]   Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma [J].
Caron, H ;
vanSluis, P ;
deKraker, J ;
Bokkerink, J ;
Egeler, M ;
Laureys, G ;
Slater, R ;
Westerveld, A ;
Voute, PA ;
Versteeg, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) :225-230
[4]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[5]   Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas [J].
Combaret, V ;
Gross, N ;
Lasset, C ;
Frappaz, D ;
Peruisseau, G ;
Philip, T ;
Beck, D ;
Favrot, MC .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :25-34
[6]  
EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO
[7]  
2-G
[8]   THE RNA COMPONENT OF HUMAN TELOMERASE [J].
FENG, JL ;
FUNK, WD ;
WANG, SS ;
WEINRICH, SL ;
AVILION, AA ;
CHIU, CP ;
ADAMS, RR ;
CHANG, E ;
ALLSOPP, RC ;
YU, JH ;
LE, SY ;
WEST, MD ;
HARLEY, CB ;
ANDREWS, WH ;
GREIDER, CW ;
VILLEPONTEAU, B .
SCIENCE, 1995, 269 (5228) :1236-1241
[9]   CORRELATING TELOMERASE ACTIVITY LEVELS WITH HUMAN NEUROBLASTOMA OUTCOMES [J].
HIYAMA, E ;
HIYAMA, K ;
YOKOYAMA, T ;
MATSUURA, Y ;
PIATYSZEK, MA ;
SHAY, JW .
NATURE MEDICINE, 1995, 1 (03) :249-255
[10]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015